Literature DB >> 12617882

Manipulation of the bacterial flora in inflammatory bowel disease.

Philippe Marteau1, Philippe Seksik, Fergus Shanahan.   

Abstract

In this chapter we summarize the clinical and experimental data which indicate that bacteria, especially from the endogenous microflora, play a role in the pathogenesis of Crohn's disease, ulcerative colitis and pouchitis. We review the clinical trials, focusing on randomized controlled trials which used antibiotics or probiotics to treat situations of IBD or prevent recurrence, and we discuss the future of this approach.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12617882     DOI： 10.1053/bega.2002.0344

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN： 1521-6918            Impact factor:   3.043


  14 in total

1.  Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease.

Authors:  Pauline D Scanlan; Fergus Shanahan; Caitlin O'Mahony; Julian R Marchesi
Journal:  J Clin Microbiol       Date:  2006-09-20       Impact factor: 5.948

2.  Development of high-throughput phenotyping of metagenomic clones from the human gut microbiome for modulation of eukaryotic cell growth.

Authors:  Karine Gloux; Marion Leclerc; Harout Iliozer; René L'Haridon; Chaysavanh Manichanh; Gérard Corthier; Renaud Nalin; Hervé M Blottière; Joël Doré
Journal:  Appl Environ Microbiol       Date:  2007-03-30       Impact factor: 4.792

3.  Microbial fingerprinting detects unique bacterial communities in the faecal microbiota of rats with experimentally-induced colitis.

Authors:  Ashis K Samanta; Valeria A Torok; Nigel J Percy; Suzanne M Abimosleh; Gordon S Howarth
Journal:  J Microbiol       Date:  2012-04-27       Impact factor: 3.422

Review 4.  Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human health.

Authors:  Volker Mai; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

Review 5.  The gastrointestinal microbiota and colorectal cancer.

Authors:  Temitope O Keku; Santosh Dulal; April Deveaux; Biljana Jovov; Xuesong Han
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-24       Impact factor: 4.052

6.  Molecular profiling of mucosal tissue associated microbiota in patients manifesting acute exacerbations and remission stage of ulcerative colitis.

Authors:  Sandeep A Walujkar; Shreyas V Kumbhare; Nachiket P Marathe; Dhrati V Patangia; Parimal S Lawate; Renu S Bharadwaj; Yogesh S Shouche
Journal:  World J Microbiol Biotechnol       Date:  2018-05-23       Impact factor: 3.312

7.  Search for localized dysbiosis in Crohn's disease ulcerations by temporal temperature gradient gel electrophoresis of 16S rRNA.

Authors:  Philippe Seksik; Patricia Lepage; Marie-France de la Cochetière; Arnaud Bourreille; Malène Sutren; Jean-Paul Galmiche; Joël Doré; Philippe Marteau
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

8.  Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for treatment of inflammatory bowel disease.

Authors:  Heejung Kim; Hyesik Kong; Boim Choi; Youngwook Yang; Youngmi Kim; Mi Jung Lim; Len Neckers; Yunjin Jung
Journal:  Pharm Res       Date:  2005-08-24       Impact factor: 4.200

9.  Utility of the Nonabsorbed (<0.4%) Antibiotic Rifaximin in Gastroenterology and Hepatology.

Authors:  Chinyu G Su; Faten Aberra; Gary R Lichtenstein
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-03

10.  Randomized, controlled trial evaluating the effect of multi-strain probiotic on the mucosal microbiota in canine idiopathic inflammatory bowel disease.

Authors:  Robin White; Todd Atherly; Blake Guard; Giacomo Rossi; Chong Wang; Curtis Mosher; Craig Webb; Steve Hill; Mark Ackermann; Peter Sciabarra; Karin Allenspach; Jan Suchodolski; Albert E Jergens
Journal:  Gut Microbes       Date:  2017-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.